Clinical Trials Logo

Cesarean Delivery clinical trials

View clinical trials related to Cesarean Delivery.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06058208 Completed - Preterm Labor Clinical Trials

Baby Smell Visual Stimulus Program Cortical and Breast Oxygenation Milk Amount Mother-Infant Attachment

Start date: August 19, 2022
Phase: N/A
Study type: Interventional

In this study, the effect of infant odor and visual stimulus program applied to mothers who had delivered by cesarean section and whose babies were taken to the NICU on cortical and breast oxygenation (rSO2), amount of breast milk and mother-infant bonding was investigated.

NCT ID: NCT05729984 Completed - Clinical trials for Cesarean Delivery Affecting Fetus

Paula Method Versus Chewing Gum for Postoperative Recovery After Caesarean Section

Start date: February 20, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effectiveness of gum chewing vs Paula exercises in patients after cesarean delivery. The main question it aims to answer is: does the Paula method hasten the time to recovery of bowel function compared to gum chewing after cesarean delivery. Participants will be asked to either chew gum or to do Paula exercises. The time to restoration of bowel function after the surgery will be measured.

NCT ID: NCT05632796 Completed - Clinical trials for Cesarean Delivery Affecting Fetus

Tailored Pfannenstiel Incision for Caesarean Delivery According to the Fetal Head Occipitofrontal Diameter

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is whether the Pfannenstiel skin incision can be adjusted according to the occipitofrontal diameter (OFD) of the fetal head.

NCT ID: NCT05494268 Completed - Pregnancy Related Clinical Trials

Effects of Preoperative Oral Carbohydrate Loading on Maternal Thiol-disulfide Homeostasis

Start date: September 13, 2022
Phase:
Study type: Observational [Patient Registry]

The primary aim of this randomised control trial is to assess the impact of pre-operative carbohydrate loading on thiol disulfide homeostasis when compared to standard care in elective cesarean section. Half of the participants will receive pre-operative carbohydrates and the other half will receive standard care.

NCT ID: NCT05290740 Completed - Cesarean Delivery Clinical Trials

Two Norepinephrine Rescue Bolus Doses for Management of Severe Post-spinal Hypotension During Elective Cesarean Delivery

Start date: March 11, 2022
Phase: Phase 4
Study type: Interventional

Maternal hypotension after spinal block is a common complication after subarachnoid block in this population whose incidence reached 60% in many reports. Hypotension is associated with maternal and neonatal complications; therefore, it is highly recommended to use vasopressors, prophylactically and interactively, for prompt control maternal blood pressure. Despite the presence of various preventive regimens (fluid loading, maternal positioning, and vasopressors), many mothers develop intraoperative episodes of hypotension which requires the use of a vasopressor bolus. Norepinephrine (NE) is an alpha adrenergic agonist with weak beta adrenergic agonistic activity; and is increasingly used in obstetric anesthesia with acceptable maternal and neonatal outcomes. NE bolus could be used for rapid correction of maternal blood pressure in a dose which variedranged between 3.7-10 mcg. Till date, al the available data for the management of maternal hypotension did not differentiate between severe and non-severe hypotension. The incidence of severe maternal hypotension (systolic blood pressure ≤60% of baseline) ranged between 7-20%. In a recent report, Hassabelnaby et al compared 6 mcg and 10 mcg NE boluses in management of maternal hypotension and found that the doses had the same success rate (≈90%); however, most of the participants in the mentioned study had non-severe hypotension. Therefore, we hypothesize that severe hypotension should be separately investigated for the possible superiority of the higher over the lower dose of NE bolus. Insufficient NE bolus would lead to failed management and prolonged hypotensive episode, whereas a higher dose might lead to reactive hypertension and/or bradycardia, which is sometimes severe. Therefore, determining the optimum dose for NE bolus would enable proper control of maternal hemodynamic profile

NCT ID: NCT04812223 Completed - Cesarean Delivery Clinical Trials

Timing of Umbilical Cord Clamping in Term Cesarean Deliveries

Start date: March 25, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to show that delayed umbilical cord clamping or milking of the umbilical cord in pregnant women undergoing elective cesarean delivery might have better effects than early clamping, on neonatal results without causing maternal hemorrhage or negatively affecting the neonatal outcome , and to compare the superiority of these three methods to each other.

NCT ID: NCT04799587 Completed - Pregnancy Related Clinical Trials

Accupressure of P6 to Reduce Nausea During Cesarean Section

Start date: May 26, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if the addition of P6 pressure point stimulation as opposed to sham-point stimulation will decrease intraoperative and postoperative nausea and vomiting (IONV and PONV) for patients undergoing non-emergent cesarean delivery. We hypothesize that the addition of stimulation of the P6 pressure point to our institutional current standard of care (phenylephrine infusion, intravenous fluid bolus, and as needed intraoperative ondansetron) will decrease the occurrence of intraoperative emesis.

NCT ID: NCT04601246 Completed - Opioid Use Clinical Trials

Understanding the Postpartum Pain Experience in Women of Minority Race/Ethnicity

Start date: December 1, 2020
Phase:
Study type: Observational

This study will evaluate women's experiences with pain management and perceived attitudes regarding opioid use for postpartum pain management and examine differences by race/ ethnicity. Women will participate in in-depth qualitative interviews regarding their postpartum pain experience after a cesarean delivery. In this cohort, the investigators will evaluate how experiences of postpartum pain management and perceptions of provider attitudes vary across self-identified race/ethnicity. When applicable, mixed methods integration of patient-reported and clinical data from NNM2 will also allow exploration of patient factors contributing to such variation.

NCT ID: NCT04358757 Completed - Cesarean Delivery Clinical Trials

Immune and Physical Recovery Following Cesarean Delivery

Start date: November 22, 2019
Phase:
Study type: Observational

Pregnancy results in an altered immune state compared to the nonpregnant population. A significant proportion of women undergoing cesarean delivery recover poorly. The first step to determining whether this is an immune driven / associated process is to characterise what effects this surgery has on maternal immune function. "Normal" changes will be evaluated in maternal immune function and activity precipitated by surgery and delivery of the neonate. Immune response to surgery will be compared to historical immune data from patients undergoing non-obstetric surgery (orthopaedic patients).

NCT ID: NCT04349215 Completed - Cesarean Delivery Clinical Trials

Validation of the Chinese ObsQoR-11

Start date: March 9, 2020
Phase:
Study type: Observational

Investigation of post-cesarean recovery among Taiwanese pregnant women.